Department of Biomedical Sciences

  1. Published

    Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists

    Kielgast, U., Holst, Jens Juul & Madsbad, Sten, Nov 2009, In: Current Diabetes Reviews. 5, 4, p. 266-75 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients

    Kataria, Y., Ellervik, Christina & Mandrup-Poulsen, Thomas, 2019, In: Seminars in Immunopathology. 41, 4, p. 413-425

    Research output: Contribution to journalReviewResearchpeer-review

  3. Published

    Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.

    Holst, Jens Juul, 2004, In: Expert Opinion on Emerging Drugs. 9, 1, p. 155-66 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

    Hansen, K. B., Knop, Filip Krag, Holst, Jens Juul & Vilsbøll, Tina, 2009, In: International Journal of Clinical Practice. 63, 8, p. 1154-60 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Treatment of type 2 diabetes with glucagonlike peptide 1

    Holst, Jens Juul, 1998, In: Current Opinion in Endocrin. and Diabetes. 5, p. 108-115

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. E-pub ahead of print

    Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab: A case series of eight patients

    Feldborg, S. E. B., Thomsen, Simon Francis & Vestergaard, C., 2024, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venereology.

    Research output: Contribution to journalLetterResearchpeer-review

  7. Published

    Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

    Iepsen, E. W., Lundgren, J., Dirksen, C., Jensen, J., Pedersen, Oluf Borbye, Hansen, Torben, Madsbad, Sten, Holst, Jens Juul & Torekov, Signe Sørensen, 2015, In: International journal of obesity (2005). 39, 5, p. 834-41 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB

    pjx571, pjx571, Lundgren, Jens, Albrechtsen, Nicolai Jacob Wewer, Mahendran, Y., Iepsen, E. P. W., Finocchietto, P., Jonsson, Anna Elisabet, Madsbad, Sten, Holst, Jens Juul, drb459, drb459, Hansen, Torben & Torekov, Signe Sørensen, 2017, In: Obesity Science & Practice. 3, 4, p. 425-433 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Treatment with the gap junction modifier rotigaptide (ZP123) reduces infarct size in rats with chronic myocardial infarction.

    Haugan, K., Marcussen, N., Kjølbye, A. L., Nielsen, Morten Schak, Hennan, J. K. & Petersen, J. S., 2006, In: Journal of Cardiovascular Pharmacology. 47, 2, p. 236-42 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Treatments for paroxysmal supraventricular tachycardia: A review of current practice

    Rajan, D. & Schmitt, Nicole, 2020, In: World Heart Journal. 12, 3, p. 257-268

    Research output: Contribution to journalReviewResearchpeer-review